Methotrexate-Related AEs Profiled in Early Rheumatoid Arthritis

WEDNESDAY, Feb. 9, 2022 -- Adverse events are common among patients during the first year of treatment with methotrexate for early rheumatoid arthritis, according to a study published online Jan. 25 in Rheumatology. Ahmad A. Sherbini, from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news